Showing 1181-1190 of 1945 results for "".
Ready to Embrace the Newest Dry Eye Drop?
https://modernod.com/articles/significant-findings/ready-to-embrace-the-newest-dry-eye-drop/37850/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatNew Study Compares Myopia Control Methods
https://modernod.com/articles/significant-findings/new-study-compares-myopia-control-methods/37849/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatGlaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-migs-technology-certified-in-europe-new-phase-3-data-for-presbyopia-drop/37091/Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia.Industry Insider
https://modernod.com/topics/patient-care/industry-insider-2/39000/TFOS DEWS III Published
https://modernod.com/podcasts/eyewire-news-the-podcast/tfos-dews-iii-published/37089/The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug BAlcon Gains FDA Approval for Novel DED Drug
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-gains-fda-approval-for-novel-ded-drug/37087/Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more abEctropion in the Setting of Glaucoma
https://modernod.com/topics/ocular-surface/ectropion-in-the-setting-of-glaucoma/38991/The ins and outs of ocular “outies” and “innies.”The Role of Oculoplastics in Optometry
https://modernod.com/topics/ocular-surface/the-role-of-oculoplastics-in-optometry/38983/Take advantage of the clinical opportunities afforded by adopting an ocular aesthetics perspective.Unlock Your Leadership Potential: See and Inspire Beyond the Lens
https://modernod.com/topics/business/unlock-your-leadership-potential-see-and-inspire-beyond-the-lens/38962/Highlights from a recent YoungOD Connect mentoring session.Navigating the Link Between Concussions and Glaucoma
https://modernod.com/topics/glaucoma/navigating-the-link-between-concussions-and-glaucoma/38955/A direct causal link has not been conclusively established, but there could be potential implications.